vanilmandelic acid has been researched along with Leukemia in 2 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Helson, L | 1 |
Johnson, GA | 1 |
Smith, R | 1 |
Bostrom, B | 1 |
Mirkin, BL | 1 |
2 other studies available for vanilmandelic acid and Leukemia
Article | Year |
---|---|
DOPA metabolism in neuroblastoma.
Topics: Adolescent; Bone Neoplasms; Brain Neoplasms; Child; Dihydroxyphenylalanine; False Negative Reactions | 1980 |
Elevation of cerebrospinal fluid catecholamine metabolites in patients with intracranial tumors of neuroectodermal origin.
Topics: Brain Neoplasms; Eye Neoplasms; Glycols; Homovanillic Acid; Humans; Leukemia; Methoxyhydroxyphenylgl | 1987 |